44 Also, anergic cells Typically keep the next susceptibility to apoptosis Except if anti-apoptotic proteins for example BCL2 are overexpressed, as is the case for CLL cells.forty five In fact, most key therapeutic innovations occurring in the last decade are linked to the inhibition of BCR and BCL2-mediated signaling. Diketahui, https://neilt999ohz0.izrablog.com/profile